10 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
DIabetes REsearCh on patient sTratification (DIRECT)
Date du début: 1 févr. 2012, Date de fin: 31 janv. 2019,
The overarching aims of the DIRECT consortium, consisting of 20 leading academic groups in diabetes and 5 EFPIA companies, are to identify biomarkers that address current bottlenecks in diabetes drug development and to develop a stratified medicines approach to treatment of type 2 diabetes with either existing or novel therapies.There is heterogeneity in who develops diabetes, the rate at which th ...
Voir le projet
27
Participants partenaires
TERMINÉ
Nanometrology Standardization Methods for Magnetic Nanoparticles (NANOMAG)
Date du début: 1 nov. 2013, Date de fin: 31 oct. 2017,
The NanoMag project is to improve and redefine existing analyzing methods and in some cases, to develop new analyzing methods for magnetic nanostructures. Using improved manufacturing technologies we will synthesize magnetic nanoparticles with specific properties that will be analyzed with a multitude of characterization techniques (focusing on both structural as well as magnetic properties) and b ...
Voir le projet
18
Participants partenaires
TERMINÉ
Molecular technology for nuclear imaging and radionuclide therapy (TRACEnTREAT)
Date du début: 1 oct. 2012, Date de fin: 30 sept. 2016,
Cancer is undoubtedly becoming the second largest cause of death in the EU. Future predictions are very somber expecting worldwide 17.5 million deaths and 27 million new cases annually by 2050. New innovative research and properly educated generation of young scientists in fields related to cancer prevention, diagnostics, treatment and management is the only way to ensure progress in solving this ...
Voir le projet
7
Participants partenaires
TERMINÉ
Personalized Medicine 2020 and beyond – Preparing Europe for leading the global way (PerMed) (PERMED)
Date du début: 1 sept. 2013, Date de fin: 31 août 2015,
The Health Directorate of the European Commission's DG Research and Innovation recently stated that Personalized Medicine is one of the most innovative areas in the future of health research with a high potential for patients, citizens and the economy. However, today the full potential can not be developed due to fragmented activities, insufficient communication and lack of generic solutions in th ...
Voir le projet
18
Participants partenaires
TERMINÉ
Magnetic Isolation and moleculaR Analysis of single CircuLating and disseminated tumor cElls on chip (MIRACLE)
Date du début: 1 sept. 2010, Date de fin: 31 mai 2015,
Cancer remains a prominent health concern afflicting modern societies. Continuous innovations and introduction of new technologies are essential to level or even reduce current healthcare spending. As the analysis of occult tumour cells (OTC) in blood or bone marrow is most promising in this respect, MIRACLE aims to develop a low-cost, fully automated, integrated lab-on-a-chip (LOC) system for the ...
Voir le projet
15
Participants partenaires
TERMINÉ
Construction kit for tailor-made vascularized boneimplants (VascuBone)
Date du début: 1 janv. 2010, Date de fin: 31 mars 2015,
The goal of VascuBone is to develop a “tool box” for bone regeneration, which on one hand fulfils basic requirements and on the other hand is freely combinable with what is needed in the respective patient’s situation. The tool box will include a variation of biocompatible biomaterials and cell types, FDA approved growth factors, material modification technologies, simulation and analytical tools ...
Voir le projet
18
Participants partenaires
TERMINÉ
Harmonised eCall European Pilot - Phase 2 (HeERO2)
Date du début: 1 janv. 2013, Date de fin: 31 déc. 2014,
The overall objective of HeERO 2 is "To extend HeERO to new Member States or associated countries to demonstrate the scalability of the HeERO solution and to widen the acceptance of eCall."To support this objective there are three aims:(1) to prepare the necessary infrastructure to realize interoperability of "eCall" at European level, (2) to boost Member States investment in the PSAP infrastructu ...
Voir le projet
42
Participants partenaires
TERMINÉ
Novel high-performance enzymes and micro-organisms for conversion of lignocellulosic biomass to bioethanol (NEMO)
Date du début: 1 mai 2009, Date de fin: 30 avr. 2013,
The NEMO project provides novel efficient enzymes and microbes for 2nd generation bioethanol production. It generates through metabolic engineering and mutagenesis & screening approaches robust yeast strains that have a broad substrate range and can (co-)ferment C6 and C5 sugars to ethanol with high productivity (rate and yield), and that are significantly more stress tolerant, i.e. inhibitor, eth ...
Voir le projet
21
Participants partenaires
TERMINÉ
Biofunctionalized Metal and Magnetic Nanoparticles for Targeted Tumor Therapy (NANO3T)
Date du début: 1 août 2008, Date de fin: 31 juil. 2011,
The cause of diseases is often unknown, but their origin can frequently be found at the biomolecular and cellular level situated on nm-scale. Early diagnostics combined with early intervention on that nanoscale is one of the holy grail of modern medicine. Inorganic nanoparticles are very promising agents in that respect. One of the promising biomedical applications of these nanoparticles is their ...
Voir le projet
8
Participants partenaires
TERMINÉ
Understanding plant diversity maintenance in a multi-species metapopulation system in highly variable fire prone environment (PLANT METAPOPULATION)
Date du début: 1 nov. 2007, Date de fin: 31 oct. 2010,
Mediterranean-climate ecosystems (e.g. Mediterranean Basin, Southwest Australia) are biodiversity hot spots for vascular plants. Some fire adapted plant species of the Proteaecae family of the South African Cape floristic region and the Southwest Australia n sandplains, which are killed by fires (non-sprouters) and storing their seeds in canopies (serotiny), are one of the rare examples of real pl ...
Voir le projet